nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
But Why Weight: Understanding the Implications of Obesity in Kidney Transplant
|
Vranic, Gayle |
|
|
41 |
4 |
p. 380-391 |
artikel |
2 |
Dialysis of the Obese Patient: Meeting Needs for a Growing Epidemic
|
Choudhury, Devasmita |
|
|
41 |
4 |
p. 371-379 |
artikel |
3 |
Editorial Board
|
|
|
|
41 |
4 |
p. A1 |
artikel |
4 |
Introduction: Obesity and the kidney
|
Kopp, Jeffrey B. |
|
|
41 |
4 |
p. 295 |
artikel |
5 |
Masthead
|
|
|
|
41 |
4 |
p. IFC |
artikel |
6 |
Nuclear Receptors and Transcription Factors in Obesity-Related Kidney Disease
|
Jones, Bryce A. |
|
|
41 |
4 |
p. 318-330 |
artikel |
7 |
Obesity Management and Chronic Kidney Disease
|
Chen, Yang |
|
|
41 |
4 |
p. 392-402 |
artikel |
8 |
Obesity-Related Glomerulopathy: Clinical Management
|
Herman-Edelstein, Michal |
|
|
41 |
4 |
p. 358-370 |
artikel |
9 |
Podocytopathy in Obesity: Challenges of Living Large
|
Giannini, Gabriel |
|
|
41 |
4 |
p. 307-317 |
artikel |
10 |
Renal Cellular Autophagy in Obesity: Boon or Bane?
|
Ghandriz, Ramyar |
|
|
41 |
4 |
p. 349-357 |
artikel |
11 |
Sodium Glucose Transporter, Type 2 (SGLT2) Inhibitors (SGLT2i) and Glucagon-Like Peptide 1-Receptor Agonists: Newer Therapies in Whole-Body Glucose Stabilization
|
Shepard, Blythe D. |
|
|
41 |
4 |
p. 331-348 |
artikel |
12 |
Table of Contents
|
|
|
|
41 |
4 |
p. A3 |
artikel |
13 |
The Renal Pathology of Obesity: Structure-Function Correlations
|
Tsuboi, Nobuo |
|
|
41 |
4 |
p. 296-306 |
artikel |